RESEARCH—HUMAN—CLINICAL STUDIES
TOPIC
RESEARCH—HUMAN—CLINICAL STUDIES
Endoscopic Endonasal Approach for
Nonvestibular Schwannomas
Samuel S. Shin, PhD*
Paul A. Gardner, MD‡
S. Tonya Stefko, MD§
Ricky Madhok, MD‡
Juan C. FernandezMiranda, MD‡
Carl H. Snyderman, MDk
*University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania;
Departments of ‡Neurological Surgery,
§Ophthalmology, and kOtolaryngology,
University of Pittsburgh Medical Center,
Pittsburgh, Pennsylvania
Correspondence:
Paul A. Gardner, MD,
Department of Neurological Surgery,
University of Pittsburgh Medical Center,
UPMC Presbyterian,
Ste B-400, 200 Lothrop St,
Pittsburgh, PA 15213.
E-mail: gardpa@upmc.edu
Received, September 1, 2010.
Accepted, March 25, 2011.
Published Online, March 25, 2011.
BACKGROUND: Nonvestibular schwannomas of the skull base often represent
a challenge owing to their anatomic location. With improved techniques in endoscopic
endonasal skull base surgery, resection of various ventral skull base tumors, including
schwannomas, has become possible.
OBJECTIVE: To assess the outcomes of using endoscopic endonasal approach (EEA) for
nonvestibular schwannomas of the skull base.
METHODS: Seventeen patients operated on for skull base schwannomas by EEA at the
University of Pittsburgh Medical Center from 2003 to 2009 were reviewed.
RESULTS: Three patients underwent combined approaches with retromastoid craniectomy (n = 2) and orbitopterional craniotomy (n = 1). Three patients underwent multistage
EEA. The rest received a single EEA operation. Data on degree of resection were found for
15 patients. Gross total resection (n = 9) and near-total (.90%) resection (n = 3) were
achieved in 12 patients (80%). There were no tumor recurrences or postoperative cerebrospinal fluid leaks. In 3 of 7 patients with preoperative sensory deficits of trigeminal
nerve distribution, there were partial improvements. Patients with preoperative reduced
vision (n = 1) and cranial nerve VI or III palsies (n = 3) also showed improvement. Five
patients had new postoperative trigeminal nerve deficits: 2 had sensory deficits only, 1 had
motor deficit only, and 2 had both motor and sensory deficits. Three of these patients had
partial improvement, but 3 developed corneal neurotrophic keratopathy.
CONCLUSION: An EEA provides adequate access for nonvestibular schwannomas invading the skull base, allowing a high degree of resection with a low rate of complications.
KEY WORDS: Cranial, Endonasal, Endoscopic, Schwannoma
Copyright ª 2011 by the
Congress of Neurological Surgeons
Neurosurgery 69:1046–1057, 2011
DOI: 10.1227/NEU.0b013e3182287bb9
S
chwannomas are benign tumors that arise
from Schwann cells, affecting peripheral,
autonomic, and cranial nerves (CNs).
They account for 8% to 10% of intracranial
tumors1 and occur mostly in patients between
20 and 50 years of age.2 Patients affected by
schwannoma may be asymptomatic or present
with symptoms related to the nerve of origin or
surrounding nerves. Depending on the location,
size, and nerve of origin, they can manifest
in a variety of motor and sensory symptoms,
including muscle weakness, pain, numbness,
paresthesia, and sensory deficit.
ABBREVIATIONS: CN, cranial nerve; EEA, endoscopic endonasal approach; ICA, internal carotid
artery; RMC, retromastoid craniectomy
1046 | VOLUME 69 | NUMBER 5 | NOVEMBER 2011
www.neurosurgery-online.com
The most common intracranial schwannomas
involve the vestibular nerve, with an annual
incidence of 1 in 100 000.3 Treatment strategies
for these tumors have been studied extensively
and range from observation to radiosurgery
to microsurgical resection with middle fossa,
translabyrinthine, or retrosigmoid approaches.4,5
Nonvestibular schwannomas are less common,
and their resection strategies are not as thoroughly investigated. Previous studies on surgical
treatments of nonvestibular schwannoma looked
at microsurgical approaches6 or a combination of
radiosurgery and microsurgery.7 In the Sarma
et al6 report of microsurgical resection of nonvestibular schwannomas, new CN deficits
were observed in 24% of the patients, and the
most common postoperative morbidity was
cerebrospinal fluid (CSF) leak, which occurred
www.neurosurgery-online.com
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
ENDONASAL ENDOSCOPIC APPROACH FOR SCHWANNOMAS
in 10.9% of patients. In the Safavi-Abbasi et al7 study, new CN
deficits were identified in 14.3% of nonvestibular schwannomas
treated by microsurgical resection alone. Those treated by
radiosurgery alone had new CN deficits in 22.2% of the cases.
The rate of CSF leak after microsurgical resection was reported in
12% of the patients (6 of 50 cases).
Reports of functional outcomes of patients who underwent
microsurgical resection of trigeminal schwannoma, which make
up the majority of nonvestibular schwannomas, have been
favorable. In a report by Dolenc,8 there were no new neurological
deficits after the microsurgical resection of trigeminal schwannoma other than temporary corneal sensory deficits in 2 of 85
cases. There were improvements in preoperative CN deficits in
many patients; the largest improvements were seen for CN VI
deficit (45% preoperatively to 9% postoperatively) and CN V
sensory deficit (100% preoperatively to 85% postoperatively).
However, there was no improvement in atrophy of temporalis
and masseter muscles after surgery. Unlike these various studies
that assessed outcomes after using microsurgical approaches, the
effectiveness of the endoscopic endonasal approach (EEA) in the
treatment of nonvestibular schwannomas has not been reported.
Complete resection is the treatment of choice for schwannomas because subtotal resection of vestibular schwannomas may
result in higher recurrence rates compared with near-total or gross
total resections.9 This may be difficult when the tumor invades
CNs and important vascular structures of the skull base, and
subtotal resection is often performed to preserve neural or
vascular integrity.10 Although various surgical approaches such as
middle fossa, retrosigmoid, infratemporal, and translabyrinthine
approaches are good options for resection of skull base
schwannomas, EEA can provide a direct approach for tumors in
and around the paranasal sinuses and skull base. We report the
role of EEA in the resection of nonvestibular schwannomas of the
cranial base in 17 patients.
placed supine with his/her head fixed by a 3-pin head holder and held in
neutral position with slight neck turn to right side. A 0.05% oxymetazoline was applied topically with pledgets to decongest the nose.
Throughout all operations, somatosensory evoked potentials and CN
electromyography (as indicated) were monitored. The procedure was
initiated with a right-sided middle turbinectomy to provide space for
suction and endoscope. The left middle turbinate was lateralized for
passing of additional instruments.
For the purpose of flap reconstruction at the end, nasoseptal flaps were
harvested for some patients. This technique has been well described
previously.12,13 The flap was raised at the beginning of the surgery and
stored in nasal cavity or maxillary sinus until reconstruction.
Sphenoid Sinus Exposure
For the patients in this series with anterior and middle skull base
schwannomas, sphenoid sinus exposure was performed initially. The floor of
the sphenoid sinus was drilled bilaterally with a 0° endoscope, handheld
irrigation, and a 3-mm hybrid cutting/diamond burr. A wide bilateral
sphenoidotomy was necessary to allow easy access of endoscope and instruments in critical situations such as in the event of bleeding of the internal
carotid artery (ICA). In certain cases, when ICA control was important for
tumor resection around or posterior to the ICA, bone over the paraclival and
petrous horizontal parts of the ICA was thinned and removed. The floor of
the sphenoid sinus was widened laterally to access areas lateral to the ICA,
and access increased anteriorly by removal of posterior ethmoid air cells.
Transplanum/Transcribriform Exposure
In the case of olfactory schwannoma (patient 17), the tumor was
approached by exposure of planum sphenoidale and cribriform plate.
After exposure of the sphenoid sinus and removal of ethmoid air cells,
superior attachment of nasal septum was resected up to the skull base.
Anterior and posterior ethmoid arteries were cauterized bilaterally during
the approach. Planum sphenoidale and cribriform plate and the medial
and superior aspects of orbit were drilled to access the tumor, which was
then internally debulked before performing extra capsular dissection.
Meckel Cave Exposure
This retrospective case series study was approved by the University of
Pittsburgh Medical Center Institutional Review Board. Patient records
from February 2003 to August 2009 were reviewed retrospectively. All
skull base schwannoma cases that underwent EEA at the University of
Pittsburgh Medical Center were reviewed. Vestibular schwannoma cases
were not included in this study because they are not deemed appropriate
for EEA.
Operative notes, radiographic images, and office notes were used for
data collection of presentations, clinical outcomes, demographics, and
surgical details. Multiple surgical corridors were considered for each case
as previously described.11 In some patients, a combination of EEA and
open retromastoid craniectomy (RMC) or EEA and open orbitopterional
craniotomy was performed to provide optimal access while minimizing
brain retraction and risk to neighboring neurovascular structures.
For schwannomas of Meckel cave, exposure began by accessing the
maxillary sinus as previously described.14 Nasal antrostomy was performed with backbiting rongeurs. The maxillary sinus ostium was
opened widely, and sphenopalatine foramen was identified. The posterior wall of the maxillary sinus was removed with a Kerrison rongeur,
and the pterygopalatine fossa was thereby exposed. Removal of the
posterior wall continued to the area just lateral to the infraorbital
foramen. At this point, the vidian nerve and artery were visualized at the
confluence of the medial pterygoid plate and floor of sphenoid sinus.15
Image guidance was used to confirm the location of the ICA and vidian
canal. The wall of the vidian canal was then drilled cautiously when ICA
control was necessary. For access to Meckel cave, the vidian nerve was
usually sacrificed, and the artery (when present) was coagulated by bipolar electrocautery and transected. Foramen rotundum was identifiable
lateral to the vidian canal, and the bone around V2 was drilled until the
insertion of V2 into dura mater at the middle cranial fossa was visible.
Preparation for EEA
Infratemporal Fossa Exposure
All patients underwent EEA by a team composed of an otolaryngologist and a neurosurgeon using a binarial approach. The patient was
After initial sphenoid sinus exposure, the posterior aspect of the inferior turbinate was resected and a wide nasal antrostomy was performed.
METHODS
NEUROSURGERY
VOLUME 69 | NUMBER 5 | NOVEMBER 2011 | 1047
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
SHIN ET AL
Through this window, the posterior wall of the maxillary sinus was
accessed and removed with Kerrison rongeurs. Branches of the internal
maxillary artery, greater palatine artery, posterior nasal artery, and
sphenopalatine arteries were transected after bipolar cauterization.
The pterygoid plates were then drilled to fully expose the infratemporal
fossa tumor.
Orbital Apex Exposure
After removal of posterior and anterior ethmoidal air cells, exposure
of the orbital apex was started by removing the posterior lamina
papyracea. Then the entire optic canal was exposed posteriorly to the
lateral edge of the tuberculum sellae. Further bone removal over the
superior orbital fissure and optic canal proceeded to expose the tumor
in the orbital apex.
Jugular Fossa Exposure
The jugular foramen approach is also called the infrapetrous16 or
sublacerum (A.L. Rhoton, MD, personal communication, 2010)
approach. The jugular foramen, which is formed by the clival bone
(medial) and the petrous bone (lateral), sits at the caudal opening of the
petroclival fissure. For exposure into the jugular fossa, the initial opening
into the sphenoid sinus was followed by removal of the sphenoid sinus
floor and subjacent clival bone. Drilling in the clival region was extended
laterally toward the jugular tubercle region, as previously described.17 The
vidian canal was identified laterally, and the pterygoid body and medial
plate inferior to the vidian canal were completely drilled out. The
infrapetrous approach to the jugular foramen is a transpterygoid
infravidian approach. The thick tissue of the pharyngobasilar fascia was
stripped down, and the mucosa and fibrocartilage between the nasopharynx and Eustachian tube were then dissected. The image guidance
system and Doppler were used to identify and avoid the ICA in the
parapharyngeal space as dissection continued laterally. To access the
inferior surface of the petrous bone and jugular foramen, the torus tubarius
was transected at the nasopharynx and displaced inferiorly and laterally.
This key maneuver allowed the opening of the sublacerum route to the
target. The diamond drill was used to further remove the bone around the
genu of the lacerum segment of the ICA without exposing the artery. It is
critical to note that at the jugular foramen the pars nervosa is anterior to the
pars venosa; therefore, the ventral (endonasal) approach to the jugular
foramen is suitable only for lesions extending ventrally and displacing the
lower CNs out of the endonasal trajectory.
Combined Craniotomy Approaches
The posterior components of schwannomas invading the cerebellopontine
angle were resected by a standard retromastoid approach. Orbitopterional
craniotomy was used to access tumor that extended anterior and lateral to the
optic nerve and superior orbital fissure.
Reconstruction
Nasal septal flap was used in the more recent patients (n = 9) who
underwent EEA. At the end of the dissection, a Duragen (Integra Life
Sciences, Boston, Massachusetts) inlay was placed over the dural defect.
Nasal septal flap prepared before approaching the tumor was placed over
this layer of inlay and was fixed by dural sealant. Fat autograft or Gelfoam
was placed superficially over the flap to support the construct. Occasionally, an inflated Foley catheter balloon was placed over the various
layers of reconstruction to prevent the construct from migrating.
1048 | VOLUME 69 | NUMBER 5 | NOVEMBER 2011
RESULTS
Between 2003 and 2009, 17 patients had nonvestibular
schwannomas operated on by EEA (Table). There were 8 male
(47%) and 9 female (53%) patients with a mean age of 36.5 years
(range, 14-72 years). The lesions approached via EEA originated
in various areas around the skull base. There were 11 trigeminal
schwannomas located primarily in the following areas: 4 in the
Meckel cave, 2 in the middle fossa, 2 in the orbital apex, and 3 in
the infratemporal fossa. There were 1 olfactory schwannoma and
2 jugular schwannomas, and 3 were of unknown nerve of origin:
2 intranasal and 1 intraconal/orbital. Two patients were lost to
follow-up, and 1 patient’s surgery was aborted early without
tumor removal owing to limited access related to the ICA.
Average operative time was 8 hours 39 minutes when multiple
staged operations are considered 1 operation. Average operative
time for single-stage EEA surgeries was 5 hours 17 minutes,
whereas that of multistage combined surgeries was 14 hours
14 minutes (average operative time for individual stages, 6 hours
34 minutes). There were no postoperative CSF leaks. Intraoperative CSF leaks were reconstructed with Duragen (collagen
matrix) and either Alloderm (earlier in the series) or nasoseptal
flap followed by tissue sealant and packing. Average follow-up
time for the patients was 15 months.
Among the 17 patients in our case series who underwent
resection of schwannoma by EEA, we have recorded data on the
degree of resection for 15 patients. One patient had no record of
degree of resection, and another surgery was aborted because of
concern about control of the ICA. Among the remaining 15
patients, 9 patients had gross total resection (60%), 3 patients had
near-total resection (20%), and 3 patients had subtotal resection
(20%). For cases with subtotal resections, complete resection was
not planned for the operation as a result of the proximity or
involvement of critical neurovascular structures such as the
carotid artery or optic nerve. The goals of the operations were to
maximize symptom relief by debulking the tumor while minimizing morbidity from damaging these critical structures.
As mentioned, 1 case was aborted. A 33-year-old male patient
(patient 13) had a 2.5 3 1.4 3 1.6-cm schwannoma within the
right jugular foramen that was adjacent to the carotid artery and
compressing and laterally displacing the internal jugular vein. An
EEA was attempted to access this tumor. After the initial procedure and removal of inferior aspect of sphenoid sinus and part
of a clivus, dissection continued deep to the Eustachian tube
toward the hypoglossal canal. However, there was only a small
window between the lateral clival bone (medial jugular tubercle)
and the carotid artery, limiting access to the tumor. The surgery
was aborted because of concern for ICA injury. The patient was
offered a far lateral approach but elected to undergo radiosurgery
treatment 2 weeks after EEA to control the tumor.
Complications
One young female patient (patient 4) who underwent resection of
a trigeminal schwannoma by combined EEA and RMC developed
www.neurosurgery-online.com
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
ENDONASAL ENDOSCOPIC APPROACH FOR SCHWANNOMAS
TABLE. Clinical Data of Schwannoma Patients Treated by Endoscopic Endonasal Approacha
Age,
Patient y/Sex
Category
Tumor Location
Degree of
Resection Procedures
Preoperative
Symptoms
Postoperative
Complications
V1. V2. V3 numbness
HA
1
51/M
Trigeminal
Infratemporal,
Meckel cave
Near total
EEA
2
46/F
Trigeminal
Orbital apex,
Meckel cave
Gross total
EEA
3
24/M
Trigeminal
Meckel cave
Subtotal
EEA
4
19/F
Trigeminal
Meckel cave,
CP angle
Near total
5
23/F
Trigeminal
Middle fossa,
Meckel cave
Gross total
EEA
V1, V2, V3
numbness,
CN VI palsy
6
21/F
Trigeminal
Meckel cave
Gross total
EEA
7
49M
Trigeminal
Gross total
8
34/M
Unknown
Middle fossa,
posterior fossa
Intraconal, orbital
EEA,
RMC
EEA,
OPC
V1, V2, V3 pain/numbness,
mastication weakness,
corneal abrasion,
neurotrophic cornea
Dry eye, CN X palsy
V1, V2 numbness,
mild CN X palsy
(after RMC)
V1 numbness, optic
CN III palsy
neuropathy
9
34/F
Trigeminal
Near total
10
11
12
72/M
26/F
20/F
Trigeminal
Jugular
Trigeminal
Infratemporal,
middle fossa
Orbital apex
Jugular fossa
Meckel cave
3-Stage V1, V2, V3 numbness,
EEA
CN VI palsy
Gross total
EEA
Reduced vision
Subtotal 2-Stage EEA
Gross total
EEA
V1 numbness
13
33/M
Jugular
Jugular fossa
14
15
16
17
54/F
30/F
51/M
14/M
Trigeminal
Unknown
Unknown
Olfactory
Infratemporal
Nasal cavity
Nasal cavity
Frontal lobe
Surgery
Aborted
Gross total
Gross total
Unknown
Gross total
Subtotal
Postoperative
Improvements
Improved upper
teeth sensation,
improved HA
CN VI, CN III palsy V1 numbness/paresthesia,
neurotrophic cornea
CN VI palsy
EEA,
Dysesthesia of
RMC, GKS teeth, V1, V2
Improved CN VI, III
palsy, improved V1
paresthesia
V1, V2 numbness/pain, HA, Resolved CN VI palsy,
improved HA,
dry eye, neurotrophic
improved
cornea
sensation
of roof of mouth
V3 numbness/paresthesia
mastication muscle
weakness/atrophy, dry
eye, CN VI palsy (after
RMC)
Mastication weakness/
muscle atrophy, HA,
dry eye
HA
Resolved CN VI palsy
Improved V3
numbness,
improved HA
No mastication
weakness
Improving vision,
improving CN III
palsy
Resolved CN VI palsy
HA
HA, dry eye
Fully recovered vision
Resolved HA
Improved V1
numbness
LTF
LTF
LTF
LTF
EEA, GKS
EEA
EEA
EEA
2-Stage
EEA
LTF
LTF
HA, personality
changes
a
CN, cranial nerve; CP, cerebellopontine; EEA, expanded endonasal approach; GKS, Gamma Knife surgery; HA, headache; LTF, lost to follow-up; OPC, orbitopterional craniotomy;
RMC, retromastoid craniectomy. Near total resection indicates $90% resection; subtotal resection, ,90% resection.
a transient CN VI palsy after the RMC. A male patient (patient 8)
with an intraconal schwannoma developed a CN III palsy after EEA.
After further resection of tumor by orbitopterional craniotomy, the
CN III palsy began to improve. A preexisting voice hoarseness
caused by CN X palsy was exacerbated in 1 patient (patient 7) after
RMC (presumably resulting from intubation). This patient (patient
7) is discussed in detail in the Illustrative Cases section.
NEUROSURGERY
Five of 11 patients (45%) who had trigeminal schwannoma
developed postoperative deficits in the trigeminal nerve. Three of
these 5 patients (60%) with postoperative trigeminal nerve deficits
had partial recovery of function. Of these 5 patients, 2 had sensory
deficits only, 1 had motor deficit only, and 2 had both motor and
sensory deficits. Three of the patients experienced neurotrophic
keratopathy after EEA of tumor in the Meckel cave. In addition,
VOLUME 69 | NUMBER 5 | NOVEMBER 2011 | 1049
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
SHIN ET AL
5 patients with trigeminal schwannomas had decreased lacrimation
causing subjective dry eye after resection of tumors, presumably
a result of vidian nerve sacrifice as part of the approach.
Improvements
There were significant improvements of preoperative deficits in
8 of 15 patients (53%). Three of 7 trigeminal schwannoma
patients (43%) with preoperative trigeminal sensory deficit had
partial recovery of function. Recovery from preoperative CN VI
palsies occurred in 3 of 4 patients (75%), with one of them also
having partial recovery from CN III palsy.
Visual outcome was generally positive in patients with
schwannoma of the orbit. Visual improvement was reported after
EEA resection of a trigeminal schwannoma of orbital apex in
a male patient (patient 10). Preoperative vision in the right eye
was 20/50, but this had improved to 20/30 at 9 months postoperatively. Another male patient with orbital schwannoma of
unknown origin (patient 8) had subtotal resection because the
tumor closely involved the optic nerve. Preoperative vision was
20/30, and there was no postoperative change in his vision test
after EEA. Four years later, he presented with regrowth of the
tumor with resultant severe optic neuropathy and underwent
orbitopterional craniotomy. He did not have improvement from
preoperative optic neuropathy. A female patient (patient 2) with
trigeminal schwannoma of the left orbital apex also had a favorable visual outcome. She had complete CN VI palsy and partial
CN III palsy of the left eye. Her preoperative vision in the left eye
was 20/20. Postoperatively at 2.5 years, the vision was unchanged
at 20/20, and her CN VI and III palsies had nearly resolved.
ILLUSTRATIVE CASES
Patient 4
A 19-year-old female patient with sudden loss of consciousness
presented to the emergency department. On physical examination, the patient was found to be neurologically stable. Magnetic
resonance imaging (MRI) scans (Figure 1) showed enhancing
mass in the right middle and posterior fossa. Six weeks after the
initial presentation to the hospital, the patient developed rightsided numbness of the teeth and V1 and V2 distributions. The
patient underwent EEA for resection of Meckel cave component
of the tumor at this time and was followed up with RMC for
posterior fossa component 4 weeks after EEA. Near-total resection was achieved after both surgical procedures. The patient
developed a postoperative CN VI palsy, trigeminal distribution
numbness, and mastication weakness 1 month after RMC. By 4
months postoperatively, the CN VI palsy completely resolved,
but V2 and V3 complete anesthesia and V1 partial anesthesia
resulted. To treat the residual trigeminal schwannoma, which was
6% of original volume, the patient received radiosurgery at 17
months after RMC. Patient examination 5 months after radiosurgery showed improvement in sensation to 80% for V1 distribution and 70% for V2 distribution. Masseter atrophy and
slight wasting in the subtemporal fossa were also noted.
1050 | VOLUME 69 | NUMBER 5 | NOVEMBER 2011
Patient 5
A 23-year-old woman with numbness of V1, V2, and V3 distribution and CN VI palsy presented to the neurosurgical office.
A very large dumbbell-shaped V3 schwannoma in the middle fossa
extending into Meckel cave was found on radiological imaging
(Figure 2). Complete resection of the tumor was possible by EEA,
and the patient was discharged 4 days later. Temporary jaw and ear
pain developed postoperatively but resolved within weeks. The
patient also developed a dry eye, which was treated by eye drops. At
10 months postoperatively, there was wasting of left masticator
muscles. Numbness in V1 and V2 distributions recovered fully, and
V3 numbness partially recovered.
Patient 7
A 49-year-old man with a history of near-total resection of
a trigeminal schwannoma by an RMC 7 years ago presented to the
neurosurgical office with right-sided facial paresthesias. These had
developed in V1 and V2 distributions 1 year before the visit. The
patient had sensory deficits in right V1 and V2 areas and a neurogenic ulcer of his right nostril upon physical examination. A giant
schwannoma measuring 7 3 5 3 4 cm occupying the right middle
fossa and part of the cerebellopontine angle coursing along the
trigeminal nerve was revealed by MRI (Figure 3). To achieve
maximal resection of the tumor, combined operations by EEA and
RMC in 2 stages were planned. The patient underwent an EEA in
which tumor in Meckel cave, cavernous sinus, and medial wall of
the sphenoid sinus with extension into the orbital apex and infratemporal fossa was resected. The patient was discharged 1 day
after EEA. Three weeks after the EEA procedure, the patient
underwent RMC for resection of residual posterior fossa contents
of the schwannoma. Total resection was achieved by these combined approaches, and MRI revealed no residual schwannoma
mass. At 3 months postoperatively, sensory deficit remained the
same as preoperatively, with 0% sensation in right V1 and V2 but
100% sensation in V3. The patient also had exacerbation in voice
hoarseness, likely a result of the intubation procedure. There were
no signs of choking, coughing, or swallowing difficulty. The
patient also developed dry eye postoperatively, which was treated
with eye drops. At the 10-month follow-up, the patient did not
have recurrence of the tumor.
Patient 9
A 34-year-old female patient presented to the emergency
department with diplopia and hypesthesia of V1, V2, and V3
distribution. Five months before surgery, the patient noticed
occasional double vision, which was found to be CN VI palsy. A
giant schwannoma of the left middle cranial fossa was found on
MRI scan, and EEA surgeries in 3 stages were performed in
a 4-week period (Figure 4). In stages 1 and 2, the infratemporal
fossa portion of the tumor was resected. In stage 3, the Meckel
cave component was resected.
After the 3 staged EEA surgeries, approximately 7% of the
original volume of tumor remained along the medial cavernous
www.neurosurgery-online.com
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
ENDONASAL ENDOSCOPIC APPROACH FOR SCHWANNOMAS
FIGURE 1. Preoperative axial (A) and coronal (C) T1-weighted MRI scans with contrast for patient 4. Postoperatively after
endoscopic endonasal approach and retromastoid craniectomy, axial (B) and coronal (D) images show near-total resection of this
trigeminal schwannoma affecting the Meckel cave and cerebellopontine angle.
sinus. Nine months after EEA, examinations revealed complete
recovery of CN VI palsy. At this time, the patient underwent
radiosurgery to treat residual schwannoma.
Patient 17
This 14-year-old male patient had a large schwannoma in the
anterior lobe. The patient had a 2-year history of headaches,
personality changes, and declining cognitive function. Neurological examination showed bilateral papilledema and
diminished sense of smell but otherwise normal findings. A large
olfactory schwannoma was found on an MRI scan (Figure 5),
and the decision was made to proceed with EEA resection of this
tumor. After the initial exposure of the tumor by transplanum
and transcribriform approach, the tumor was debulked
and biopsied. The biopsy at the time showed the presence of
NEUROSURGERY
a fibrous tumor, but a final diagnosis was not made. Because the
tumor capsule was found to be densely adherent to the left A2,
tumor resection was stopped until a definitive diagnosis was
made. Six days later, the second stage of this surgery proceeded
with a confirmed diagnosis of olfactory schwannoma. Complete
resection of the tumor was possible at this stage. Two weeks
after the surgery, the patient had no signs of CSF leak or other
complications.
DISCUSSION
The most common schwannomas of the skull base are
vestibular schwannoma,18 followed by trigeminal schwannoma,
which account for about 8% of intracranial schwannomas. Other
schwannomas of the skull base and head and neck region are
VOLUME 69 | NUMBER 5 | NOVEMBER 2011 | 1051
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
SHIN ET AL
FIGURE 2. Preoperative (A) and postoperative (B) coronal T1-weighted MRIs with contrast showing a dumbbell-shaped trigeminal schwannoma in patient 5. T2-weighted
axial images show the superior aspect of the tumor preoperatively (C) and postoperatively (D) and the inferior aspect of the tumor preoperatively (E) and postoperatively (F).
rarer, arising in the orbit, jugular foramen, nasal cavity, and
olfactory nerve sheath. Numerous previous studies have discussed
the effectiveness of radiosurgery and microsurgery on vestibular
schwannoma.19-22 However, reports on the treatment of nonvestibular schwannoma are less common. With improved techniques in endoscopic skull base surgery and intraoperative image
guidance, resection of various tumors of the ventral skull base has
become possible. The current technique of EEA has gradually
evolved to access various structures of the anterior, middle, and
posterior skull base.23,24 In this case series, we report the outcomes of 17 patients who received EEA for the treatment of
nonvestibular schwannomas.
Considering the trigeminal schwannoma cases, which make up
the largest group in this study (11 cases), 7 cases resulted in total
resection (64%), 3 cases resulted in near-total resection (27%),
and 1 case resulted in subtotal resection (9%). Given that a more
complete resection of schwannoma is correlated to a reduced rate
of recurrence, a high degree of resection is an important goal for
successful long-term treatment of schwannoma.25 Because of the
small number of cases in this report, the total resection rates
1052 | VOLUME 69 | NUMBER 5 | NOVEMBER 2011
cannot be directly compared with the rates reported in other
larger studies, which range from 70% to 94%.26-29 In addition,
the average trigeminal schwannoma resected via EEA in our
report was generally large in diameter (3.5 cm), which likely
contributed to lower total resection rates than reported in the
current literature, because a small tumor has a higher possibility
of total resection. Trigeminal schwannoma with a diameter ,2
cm had total resection 100% of the time in previous studies.27,30
In this report, 4 of 11 trigeminal schwannoma patients had
tumors that were .4 cm, with 2 requiring multiple staged
surgeries.
The direct access to trigeminal schwannoma in EEA
offers advantages similar to previously described conventional
approaches such as infratemporal fossa approach.31 There is no
need for temporal lobe exposure or retraction in either technique,
and both provide direct access to the tumor. However,
infratemporal fossa approach provides the advantage of wide
exposure of the tumor for the ease of resection, whereas EEA
provides the advantage of avoiding temporalis muscle split and
minimizing surgical opening. The optimal choice between using
www.neurosurgery-online.com
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
ENDONASAL ENDOSCOPIC APPROACH FOR SCHWANNOMAS
FIGURE 3. Preoperative axial (A) and coronal (C) T1-weighted MRIs with contrast for patient 7 showing trigeminal
schwannoma. With combined endoscopic endonasal approach and retromastoid craniectomy, gross total resection was possible, as
shown in the axial (B) and coronal (D) images.
EEA or this conventional approach will depend on the anatomic
detail of each case of trigeminal schwannoma, the patient’s
preference, and the surgeon’s level of comfort.
In our present clinical series, there was no case of recurrence of
trigeminal schwannoma. Because most of the EEA procedures on
trigeminal schwannoma in this study were performed within the
last 2 years with an average follow-up time of 15 months, the
recurrence rates of this study also cannot be compared directly
with previously reported recurrence rates after other surgical
approaches. The time to recurrence after resection of trigeminal
schwannomas varies widely, ranging from 1 to 9 years.26,28
Previous reports have also compared recurrence rates of trigeminal schwannoma after conventional surgical approaches
such as frontotemporal transsylvian, subtemporal-intradural,
subtemporal-transtentorial, and suboccipital approaches or skull
NEUROSURGERY
base approaches such as frontotemporal extradural-intradural,
fronto-orbitozygomatic, subtemporal anterior petrosal, and
presigmoid posterior petrosal approaches.32 Conventional
approaches resulted in 65% recurrence rate, and skull base
approaches resulted in 10% recurrence rate. Whether EEA is
more effective than other skull base approaches or conventional
approaches requires further follow-up evaluation of patients over
several years. In addition, the number of patients in this series is
small, making direct comparison with larger open series difficult.
The most commonly reported symptoms for trigeminal
schwannoma are numbness and paresthesia, presenting in 70% to
95% of patients.25 Other reported symptoms are facial pain,
weakness, and wasting of masticator muscles. These symptoms
were present preoperatively in 7 patients with trigeminal
schwannoma in this report. Three of these 7 patients (43%) had
VOLUME 69 | NUMBER 5 | NOVEMBER 2011 | 1053
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
SHIN ET AL
FIGURE 4. Preoperative axial (A) and coronal (C) T1-weighted MRIs with contrast for trigeminal schwannoma occupying the
middle fossa and infratemporal fossa for patient 9. Postoperative axial (B) and coronal (D) scans show near-total resection.
partial recovery from preoperative numbness in trigeminal nerve
area after the EEA procedure. Of 11 trigeminal schwannoma
patients, 2 patients (18%) developed sensory deficit only, 2
patients (18%) developed motor and sensory deficit, and 1
patient (9%) developed motor deficit only after EEA. Overall, 4
patients (36%) developed new sensory deficits, and 3 patients
(27%) developed new motor deficits postoperatively. However,
one of these patients had partial recovery of motor deficits with
resolving of jaw tightness, and 2 patients had partial recovery of
sensory deficits. This compares favorably with other surgical
approaches for trigeminal schwannoma that show higher rates of
worsened trigeminal sensory and motor outcome. In a previous
study,32 70% of the patients had worsened sensory deficits and
56% of the patients had worsened motor deficits after conventional and skull base approaches. Improvement in trigeminal
sensory deficit was achieved in 19% of the patients in this
1054 | VOLUME 69 | NUMBER 5 | NOVEMBER 2011
previous study, whereas we show improvements in 3 of 7 patients
(43%) after EEA. In general, patients appear to have low rates of
trigeminal deficits after EEA compared with conventional or skull
base approaches for resection of trigeminal schwannoma.
Another commonly reported symptom among the trigeminal
schwannoma patients was eye dryness, which resulted in 5 of
11 patients (45%). These symptoms were reported from 2 weeks to
several months after undergoing EEA and were successfully treated
with eye drops. In addition, headache was a commonly presented
preoperative symptom in trigeminal schwannoma patients. In 4 of
11 trigeminal schwannoma patients, reduction of headaches after
EEA was reported after resection of schwannoma. A few patients in
this study reported improvements in their symptoms of diplopia
after undergoing EEA resection. Among the 4 patients presenting
with preoperative CN VI palsy, 3 had improvement of CN VI
function and resolution of diplopia.
www.neurosurgery-online.com
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
ENDONASAL ENDOSCOPIC APPROACH FOR SCHWANNOMAS
FIGURE 5. T1-weighted MRI scans with contrast showing olfactory schwannoma occupying the frontal lobe in patient 17. After
2 staged endoscopic endonasal approaches, preoperative images (A and C) and postoperative images (B and D) show gross total
resection of the schwannoma.
Because schwannomas are generally slow growing and benign,
patients with orbital schwannoma are managed by a conservative
approach unless there is compression of the optic nerve and
neighboring structures, causing loss of vision, proptosis, and pain.
Preservation of vision was considered an important goal
throughout the EEA cases for schwannoma in orbital areas.
Accessing medial orbital schwannoma by craniotomic approaches
may risk trauma to the optic nerve, which can lead to visual
deterioration after surgery. However, EEA allows resection of
schwannoma involving the orbit and decompression of optic
nerve from a medial and inferior trajectory without manipulation
of the optic nerve. The visual outcomes after EEA for all 3
patients (patients 2, 8, and 10) with orbital schwannoma were
generally positive, as previously described. Vision either improved
(patient 10) or was preserved (patients 2 and 8) after EEA.
NEUROSURGERY
The 3 other types of schwannomas in this series (jugular,
olfactory, and nasal schwannoma) were less common lesions
with fewer previous reports on their optimal surgical
approaches. Jugular foramen schwannoma may arise from
CN IX or X ganglia and were previously reported to be
resected with juxtacondylar approach, 33 microsurgery,34 and
petro-occipital transsigmoid approach,35 among many other
approaches. These approaches have shown a high rate of total
or near-total resection and preservation of CN function
postoperatively. Olfactory schwannoma and nasal cavity
schwannoma are even less common than jugular schwannoma
and were mostly reported in case reports with no sizeable case
series analyzing the outcomes, rate of total resection, and rate
of recurrence after surgery. Among these nontrigeminal
schwannomas in this series, 2 of the 4 cases resulted in gross
VOLUME 69 | NUMBER 5 | NOVEMBER 2011 | 1055
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
SHIN ET AL
total resection. One other case underwent subtotal resection,
and 1 case was aborted. Both were jugular schwannoma cases,
suggesting that this approach may not be ideal. The group
performing these surgeries is well versed in conventional
approaches, which is key in offering patients an unbiased
opinion. With any new approach, there is both an anatomic
and a technical learning curve.
One of the greatest concerns after EEA is reconstruction of
the barrier separating subarachnoid space from sinonasal tract to
prevent CSF leak and to avoid meningitis and abscess formation. Fifteen patients underwent cranial base reconstruction
after EEA. Among these 15 patients, 9 received nasoseptal flap
reconstruction; 5 received reconstruction with a combination
of Tisseel, Gelfoam, or Alloderm cover; and 1 received reconstruction with free mucosal graft from the middle turbinate
(patient 10). High postoperative CSF leaks have been reported
in early EEA cases, but there have been many advances in cranial
base reconstruction techniques using neurovascular pedicled
flap of nasal septal mucosa. This made it possible to decrease the
rate of CSF leak after EEA.12,13,36 Multilayer reconstruction has
been designed using subdural collagen matrix and then extracranial acellular dermis onlay graft placement supported by fat
autograft.
The advancement of reconstruction technique is evidenced by
the fact that none of the 9 patients who received nasoseptal flap
reconstruction in this report had postoperative CSF leaks. This is
in agreement with a previous prospective study using nasoseptal
flap, which reported a low risk of CSF leak at 5%.37 The 5 other
patients who underwent EEA before 2007 were not subjected to
the novel nasoseptal flap reconstructive technique. They received
reconstruction with the synthetic materials described but fortunately had no CSF leaks.
CONCLUSION
For nonvestibular schwannomas in the anterior and posterior
skull base such as pterygopalatine fossa, infratemporal fossa,
Meckel cave, and medial orbit, EEA is a useful technique to
maximize exposure and access. It provides an additional corridor
for treating nonvestibular skull base schwannomas that does not
require brain retraction and reduces the risk of manipulating
important neurovascular structures. As a result, postoperative
complication rates are low and operative times are short among
the patients in this report. Thus, EEA allows a team consisting of
a neurosurgeon and an otolaryngologist to achieve a high rate of
total or near-total resection with a low rate of postoperative CN
deficits and CSF leak. As an addition to conventional skull base
approaches and radiosurgery, EEA provides another option in the
arsenal of the skull base surgeons. However, it should be noted
that this approach requires an experienced endoscopic skull base
team given the anatomic and technical learning curve required.
This small series is promising, but a larger series with longer
follow-up times is needed to fully understand the role of EEA in
the treatment of nonvestibular schwannomas.
1056 | VOLUME 69 | NUMBER 5 | NOVEMBER 2011
Disclosure
The authors have no personal financial or institutional interest in any of the
drugs, materials, or devices described in this article.
REFERENCES
1. Esposito F, Cappabianca P, Del Basso De Caro M, Cavallo LM, Rinaldi C,
De Divitiis E. Endoscopic endonasal transsphenoidal removal of an intrasuprasellar schwannoma mimicking a pituitary adenoma. Minim Invasive
Neurosurg. 2004;47(4):230-234.
2. Wilson JA, McLaren K, McIntyre MA, von Haacke NP, Maran AG. Nerve-sheath
tumors of the head and neck. Ear Nose Throat J. 1988;67(2):103-107, 110.
3. Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope. 2000;110(4):
497-508.
4. Smouha EE, Yoo M, Mohr K, Davis RP. Conservative management of acoustic
neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope. 2005;
115(3):450-454.
5. Shahinian HK, Eby JB, Ocon M. Fully endoscopic excision of vestibular
schwannomas. Minim Invasive Neurosurg. 2004;47(6):329-332.
6. Sarma S, Sekhar LN, Schessel DA. Nonvestibular schwannomas of the brain:
a 7-year experience. Neurosurgery. 2002;50(3):437-448.
7. Safavi-Abbasi S, Bambakidis NC, Zabramski JM, et al. Nonvestibular schwannomas: an evaluation of functional outcome after radiosurgical and microsurgical
management. Acta Neurochir (Wien). 2010;152(1):35-46.
8. Dolenc VV. Microsurgical Anatomy and Surgery of the Central Skull Base. Wien,
Austria: Springer-Verlag; 2003.
9. Bloch DC, Oghalai JS, Jackler RK, Osofsky M, Pitts LH. The fate of the tumor
remnant after less-than-complete acoustic neuroma resection. Otolaryngol Head
Neck Surg. 2004;130(1):104-112.
10. Malone JP, Lee WJ, Levin RJ. Clinical characteristics and treatment outcome for
nonvestibular schwannomas of the head and neck. Am J Otolaryngol. 2005;26(2):
108-112.
11. Pirris SM, Pollack IF, Snyderman CH, et al. Corridor surgery: the current paradigm for skull base surgery. Childs Nerv Syst. 2007;23(4):377-384.
12. Hadad G, Bassagasteguy L, Carrau RL, et al. A novel reconstructive technique after
endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap.
Laryngoscope. 2006;116(10):1882-1886.
13. Kassam AB, Thomas A, Carrau RL, et al. Endoscopic reconstruction of the
cranial base using a pedicled nasoseptal flap. Neurosurgery. 2008;63(1)(suppl 1):
ONS44-ONS52.
14. Kassam AB, Prevedello DM, Carrau RL, et al. The front door to Meckel’s cave: an
anteromedial corridor via expanded endoscopic endonasal approach: technical
considerations and clinical series. Neurosurgery. 2009;64(3)(suppl):71-82.
15. Kassam AB, Vescan AD, Carrau RL, et al. Expanded endonasal approach: vidian canal
as a landmark to the petrous internal carotid artery. J Neurosurg. 2008;108(1):177-183.
16. Kassam AB, Gardner P, Snyderman C, Mintz A, Carrau R. Expanded endonasal
approach: fully endoscopic, completely transnasal approach to the middle third of
the clivus, petrous bone, middle cranial fossa, and infratemporal fossa. Neurosurg
Focus. 2005;19(1):E6.
17. Morera VA, Fernandez-Miranda JC, Prevedello DM, et al. ‘‘Far-medial’’ expanded
endonasal approach to the inferior third of the clivus: the transcondylar and transjugular tubercle approaches. Neurosurgery. 2010;66(6)(suppl operative):211-219.
18. Prabhu SS, Demonte F. Treatment of skull base tumors. Curr Opin Oncol.
2003;15(3):209-212.
19. Kondziolka D, Lunsford LD. Future perspectives in acoustic neuroma management. Prog Neurol Surg. 2008;21:247-254.
20. Pollock BE. Vestibular schwannoma management: an evidence-based comparison
of stereotactic radiosurgery and microsurgical resection. Prog Neurol Surg.
2008;21:222-227.
21. Pollock BE, Link MJ. Vestibular schwannoma radiosurgery after previous surgical
resection or stereotactic radiosurgery. Prog Neurol Surg. 2008;21:163-168.
22. Karpinos M, Teh BS, Zeck O, et al. Treatment of acoustic neuroma:
stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys.
2002;54(5):1410-1421.
23. Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal
approach: the rostrocaudal axis, part I: crista galli to the sella turcica. Neurosurg
Focus. 2005;19(1):E3.
www.neurosurgery-online.com
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
ENDONASAL ENDOSCOPIC APPROACH FOR SCHWANNOMAS
24. Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal
approach: the rostrocaudal axis, part II: posterior clinoids to the foramen magnum.
Neurosurg Focus. 2005;19(1):E4.
25. MacNally SP, Rutherford SA, Ramsden RT, Evans DG, King AT. Trigeminal
schwannomas. Br J Neurosurg. 2008;22(6):729-738.
26. Samii M, Migliori MM, Tatagiba M, Babu R. Surgical treatment of trigeminal
schwannomas. J Neurosurg. 1995;82(5):711-718.
27. Goel A, Muzumdar D, Raman C. Trigeminal neuroma: analysis of surgical experience with 73 cases. Neurosurgery. 2003;52(4):783-790.
28. Konovalov AN, Spallone A, Mukhamedjanov DJ, Tcherekajev VA, Makhmudov UB.
Trigeminal neurinomas: a series of 111 surgical cases from a single institution. Acta
Neurochir (Wien). 1996;138(9):1027-1035.
29. Yoshida K, Kawase T. Trigeminal neurinomas extending into multiple fossae:
surgical methods and review of the literature. J Neurosurg. 1999;91(2):202-211.
30. Day JD, Fukushima T. The surgical management of trigeminal neuromas.
Neurosurgery. 1998;42(2):233-240.
31. Goel A. Infratemporal fossa interdural approach for trigeminal neurinomas. Acta
Neurochir (Wien). 1995;136(1-2):99-102.
32. Taha JM, Tew JM Jr, van Loveren HR, Keller JT, el-Kalliny M. Comparison of
conventional and skull base surgical approaches for the excision of trigeminal
neurinomas. J Neurosurg. 1995;82(5):719-725.
33. Chibbaro S, Mirone G, Makiese O, Bresson D, George B. Dumbbell-shaped
jugular foramen schwannomas: surgical management, outcome and complications
on a series of 16 patients. Neurosurg Rev. 2009;32(2):151-159.
34. Bulsara KR, Sameshima T, Friedman AH, Fukushima T. Microsurgical management of 53 jugular foramen schwannomas: lessons learned incorporated into
a modified grading system. J Neurosurg. 2008;109(5):794-803.
35. Sanna M, Bacciu A, Falcioni M, Taibah A. Surgical management of jugular
foramen schwannomas with hearing and facial nerve function preservation: a series
of 23 cases and review of the literature. Laryngoscope. 2006;116(12):2191-2204.
36. Kassam A, Carrau RL, Snyderman CH, Gardner P, Mintz A. Evolution of reconstructive techniques following endoscopic expanded endonasal approaches.
Neurosurg Focus. 2005;19(1):E8.
37. Zanation AM, Carrau RL, Snyderman CH, et al. Nasoseptal flap reconstruction of
high flow intraoperative cerebral spinal fluid leaks during endoscopic skull base
surgery. Am J Rhinol Allergy. 2009;23(5):518-521.
COMMENTS
T
he authors have demonstrated surgery of otherwise pure neurosurgical-cranial problems by an transnasal route. Although alternative
treatment options should always be explored and encouraged, the
NEUROSURGERY
approach to types of tumors treated by the authors by the nasal route
appears to complicate an otherwise straightforward and safe surgery that
has been practiced and refined for over a century. Cranial approach
provides a quick, safe, and wide exposure to the tumor. The resection can
be done under direct surgical vision of the tumor and the displaced
neural and vascular structures. The control of bleeding is also far superior
when the exposure is wide. The handling of any surgical disaster can be
more controlled. Even if elaborate basal reconstruction methods are
possible, communication of the cranial cavity with the nose should be
avoided, unless it is absolutely mandatory. The basal meninges tend to be
strong, for biological reasons. To open them is to put the meningeal
spaces and their contents into a direct communication with a microbial
cesspool called the pharynx and nasopharynx. The endoscope sets about
creating a working space by tunneling though often tightly placed vital
neural and vascular structures at the base of the brain. The dangers are far
too many.
For intracranial lesions, the nasal approach looks good from a distance
but smells foul and can leave a bad taste.
Atul Goel
Mumbia, India
his is a retrospective report reviewing the authors’ experience with
using the expanded endonasal approach (EEA) for the treatment of
nonvestibular schwannomas. The authors report its use in 17 patients in
whom EEA was used alone or in combination with open surgical approaches. The tumors most commonly treated in this series arose from
the trigeminal nerve and invaded Meckel cave. This is a well-written
report by a group well known for its experience in using the EEA for
treating intradural pathology. For such groups, advantages over conventional approaches remain unclear, although equivalency in efficacy
seems a reasonable conclusion for the limited number of cases in this
report. Whether such endoscopic approaches become a mainstream
method for treating intradural pathology remains to be seen, although in
experienced hands there is clearly a role for their use with acceptable
complication rates.
T
Nicholas C. Bambakidis
Cleveland, Ohio
VOLUME 69 | NUMBER 5 | NOVEMBER 2011 | 1057
Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.